FMP
Johnson & Johnson
JNJ
NYSE
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
144.19 USD
0.17 (0.118%)
2023
2022
2021
2020
85.16B
79.99B
78.74B
82.58B
26.55B
24.6B
23.4B
28.43B
58.61B
55.39B
55.34B
54.16B
35.56B
33.18B
34.4B
34.42B
15.05B
14.13B
14.28B
12.34B
20.11B
19.05B
20.12B
22.08B
0
0
0
0
20.11B
19.05B
20.12B
22.08B
0
500M
-526M
-2.9B
23.41B
23.19B
20.47B
16.95B
-8.35B
-2.85B
-1.76B
-3.24B
15.06B
19.36B
19.18B
16.5B
1.74B
2.99B
1.38B
1.78B
35.15B
17.94B
20.88B
14.71B
13.88
6.86
7.93
5.59
13.73
6.73
7.81
5.51
2.53B
2.61B
2.63B
2.63B
2.56B
2.66B
2.67B
2.67B
23.73B
27.17B
30.93B
27.5B
2023
2022
2021
2020
128.34B
123.06B
113.89B
110.66B
35.15B
17.94B
20.88B
14.71B
-5.05B
-6.04B
-3.46B
-3.22B
-11.77B
-11.68B
-11.03B
-10.48B
153.84B
128.34B
123.06B
113.89B
8.67B
-12.43B
-5.32B
-10.47B
2023
2022
2021
2020
19.9B
17.98B
18.96B
18.77B
7.49B
6.97B
7.39B
7.23B
-4.54B
-4.01B
-3.65B
-3.35B
16.95B
15.02B
15.22B
14.88B
2023
2022
2021
2020
511M
801M
-1.15B
2.75B
36.05B
35.25B
36.39B
33.64B
36.56B
36.05B
35.25B
36.39B
All figures are in USD.